Changlu Hu

机构：Anhui Medical University, North West Agriculture and Forestry University, Ministry of Agriculture, Ministry of Science and Technology of the People's Republic of China, Anhui Provincial Hospital, Ministry of Agriculture and Rural Affairs, Fourth Affiliated Hospital of Anhui Medical University, Northwest A&F University

发表论文 24 篇 · 总被引 381 次 · h-index 9

代表论文

• Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial (2025 · The Lancet · 被引 127)
• First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer (2025 · JAMA · 被引 70)
• A phase II study of RC48-ADC in HER2-positive patients with locally advanced or metastatic urothelial carcinoma. (2019 · Journal of Clinical Oncology · 被引 39)
• Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial (2025 · Nature Medicine · 被引 30)
• Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study (2022 · The Lancet Regional Health - Western Pacific · 被引 23)
• A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation. (2024 · Journal of Clinical Oncology · 被引 20)